HS-10506

DRUG4 trials

Sponsors

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Conditions

HealthyInsomnia Disorder

Phase 1

Phase 1a Study in Healthy Participants

Jiangsu Hansoh Pharmaceutical Co., Ltd.Healthy

Start: 2023-07-17End: 2023-12-24Target: 52Updated: 2023-07-20

Phase Ⅰb/Ⅱ Study of HS-10506 in Chinese Participants With Insomnia Disorder

Not yet recruitingNCT06279286

Jiangsu Hansoh Pharmaceutical Co., Ltd.Insomnia Disorder

Start: 2024-05-31End: 2025-01-31Target: 312Updated: 2024-04-23

Phase 3

A Study of HS-10506 in Chinese Patients With Insomnia Disorder

Not yet recruitingNCT07587385

Jiangsu Hansoh Pharmaceutical Co., Ltd.Insomnia Disorder

Start: 2026-05-29End: 2028-08-12Target: 732Updated: 2026-05-14

A Study to Evaluate the Safety of HS-10506 in Chinese Patients With Insomnia Disorder

Not yet recruitingNCT07677384

Jiangsu Hansoh Pharmaceutical Co., Ltd.Insomnia Disorder

Start: 2026-06-12End: 2029-06-30Target: 600Updated: 2026-06-30